First Trust Advisors
KMTS

First Trust Advisors’s Kestra Medical Technologies KMTS Stock Holding History

First Trust Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76M Buy
+69,237
New +$1.45M ﹤0.01% 2053

Other funds holding KMTS

AP
Andera Partners Paris $206M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors's KMTS Position: Q2 2026 in Review

First Trust Advisors opened a new position in Kestra Medical Technologies (KMTS) in Q2 2026: 69,237 shares worth $1.76M. The stake represents ﹤0.01% of the portfolio and ranks #2053 among its holdings.

67 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • First Trust Advisors held 69,237 shares of Kestra Medical Technologies worth $1.76M as of Q2 2026.
  • Kestra Medical Technologies was a new First Trust Advisors position in Q2 2026.
  • Kestra Medical Technologies made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2053 holding.
  • 67 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.